Ceti - Centro de Estudos Em Terapias Inovadoras

Curitiba 80060-240

1 studies enrolling now · 9 studies all time

What they study most

Acromegaly, Dermatitis, Atopic, Gout, Gout Flare, Hyperuricemia, Hypophosphatemic Rickets, Pulmonary Arterial Hypertension, Sjogrens Syndrome, Tophi, X-linked Hypophosphatemia

Studies at this site

• A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs — Recruiting now
• Nipocalimab in Moderate to Severe Sjogren's Disease — Running, not enrolling
• A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis — Running, not enrolling
• A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD) — Stopped early
• Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension — Running, not enrolling
• X-linked Hypophosphatemia Disease Monitoring Program — Running, not enrolling
• Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients — Completed
• A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Evolve) — Completed
• An Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Edge) — Completed